A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.

Clinical trial NCT03752294 · WITHDRAWN

Trial details

NCT number: NCT03752294
Sponsor: University of Rhode Island
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Cognitive Impairment Mild Alzheimer's Disease

Start date: 2019-05-01
Primary completion: 2022-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.